Impact of albumin-bilirubin grade on survival in patients with hepatocellular carcinoma who received sorafenib: An analysis using time-dependent receiver operating characteristic.
Toshifumi TadaTakashi KumadaHidenori ToyodaKunihiko TsujiAtsushi HiraokaKojiro MichitakaAkihiro DeguchiToru IshikawaMichitaka ImaiHironori OchiKouji JokoNoritomo ShimadaKazuto TajiriMasashi HirookaYohei KoizumiYoichi HiasaJunko TanakaPublished in: Journal of gastroenterology and hepatology (2019)
Albumin-bilirubin grade is a better predictor of survival in patients with advanced HCC who received sorafenib therapy than Child-Pugh classification.